August 16, 2021
GWEST Corporation Limited, for the three months ended June 30, 2021, booked total revenue amounting to $30.80 million, an increase of 25% when compared with the $24.16 million booked last year. Management noted, “revenue was positively impacted by a 46% increase in patient fees during the quarter relative to the corresponding quarter in the prior year. The increase in patient fees was mainly due to the relaxing of Covid-19 related curfew restrictions resulting in a greater movement of the people and longer opening hours at our facilities.”
Additionally, “Lease income increased by 12% over the corresponding quarter in the prior year as result of increase rental of lettable space. Negotiations are ongoing with a prospective tenant for a lease of 5,000 sq.ft. of office space. We expect to complete these negotiations during the second quarter.”
Cost of sales for the period amounted to $8.84 million relative to the $6.03 million reported for the same period last year. Consequently, gross profit increased 17% amounting to $21.24 million relative to the $18.12 million for the corresponding period in 2020.
Administrative expenses decreased by 30% to close the period at $9.98 million (2020: $14.20 million) and other operating expenses amounted to $19.20 million up 27% from $15.07 million for the corresponding period in 2020. Other gains or losses amounted $6.65 million (2020: $3.22 million)
As a result operating loss closed the period at $1.29 million versus a loss of $7.94 million booked twelve months earlier.
Finance cost for the period amounted to $9.53 million relative to $8.78 million booked for the comparable period in 2020. Interest income amounted to $60,000 (2020: nil)
There was no taxation charge for the period, as such, net loss for the period amounted to $10.76 million relative to a net loss $16.71 million in 2020. Total comprehensive loss for the quarter totalled $10.76 million relative to a loss $16.71 million in 2020.
Loss per share (LPS) for the period amounted $0.02 compared to and loss per share of $0.03 recorded in 2020. The trailing-twelve-month EPS amounted to $0.06. The number of shares used in the calculations is 484,848,485. GWEST closed the trading period on August 14, 2021, at $0.86 with a corresponding P/E of 14.82 times.
Balance Sheet at a glance:
As at June 30, 2021, total assets amounted to $1.67 billion, 2% more than $1.63 billion the year prior. This was as a result of the increase in ‘Property and equipment’ which closed $337.19 million (2020: $229.35 million), this due to the “increase in investment related to the build-out of our surgery center and in-patient unit,” as per GWEST. However, the movement was tempered by a decrease in ‘Due from relative parties’ which totalled $54.61 million (2020: 97.46) and ‘Right of use assets’ which closed to $97.26 million (2020: $132.63 million).
Shareholders’ Equity totalled $679.48 million (2020: $651.34 million) resulting in a book value per share of $1.40 (2020: $1.34).
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.